A sensitive label-free electrochemical immunosensor for detection of CYFRA21-1 based on 3D-G@Au

Jing Bao,Yanan Zhao,Danqun Huo,Mei Chen,Mei Yang,Huanbao Fa,Changjun Hou
DOI: https://doi.org/10.1016/j.talanta.2017.09.020
2017-01-01
Abstract:Previous studies have confirmed that CYFRA 21-1 serves as a powerful biomarker in non-small cell lung cancer (NSCLC). Herein, we report for the first time a label-free electrochemical immunosensor for sensitive and selective detection of tumor marker cytokeratin 19 fragment antigen 21-1 (CYFRA21-1). In this work, three-dimensional graphene @ gold nanoparticles (3D-G@Au) nanocomposite was modified on the glassy carbon electrode (GCE) surface to enhance the conductivity of immunosensor. The anti-CYFRA21-1 captured and fixed on the modified GCE through the cross-linking of chitosan (CS), glutaraldehyde (GA) and anti-CYFRA21-1. The DPV peak current change due to the specific interaction between anti-CYFRA21-1 and CYFRA21-1 on the modified electrode surface was utilized to detect CYFRA21-1. Under optimized conditions, the proposed electrochemical immunosensor was employed to detect CYFRA21-1 and exhibited a wide linear range of 0.25~800 ng·mL −1 and low detection limit of 100 pg·mL −1 (S/N=3). Moreover, interference from bovine serum albumin (BSA), carcinoembryonic antigen (CEA), ascorbicacid (AA), dopamine (DA) and uricacid (UA) were nearly negligible. In addition, the recovery rates of serum samples were in the range from 95.2% to 108.7%. Therefore, it is expected that the proposed immunosensor based on a 3D-G@Au has great potential in clinical medical diagnosis of CYFRA21-1.
What problem does this paper attempt to address?